185 related articles for article (PubMed ID: 14652810)
1. Sinonasal adenocarcinoma: evidence for histogenetic divergence of the enteric and nonenteric phenotypes.
Choi HR; Sturgis EM; Rashid A; DeMonte F; Luna MA; Batsakis JG; El-Naggar AK
Hum Pathol; 2003 Nov; 34(11):1101-7. PubMed ID: 14652810
[TBL] [Abstract][Full Text] [Related]
2. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma.
Kennedy MT; Jordan RC; Berean KW; Perez-Ordoñez B
J Clin Pathol; 2004 Sep; 57(9):932-7. PubMed ID: 15333652
[TBL] [Abstract][Full Text] [Related]
3. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract][Full Text] [Related]
4. Villin, cytokeratin 7, and cytokeratin 20 expression in pulmonary adenocarcinoma with ultrastructural evidence of microvilli with rootlets.
Tan J; Sidhu G; Greco MA; Ballard H; Wieczorek R
Hum Pathol; 1998 Apr; 29(4):390-6. PubMed ID: 9563790
[TBL] [Abstract][Full Text] [Related]
5. Cytokeratin expression patterns in noncardia, intestinal metaplasia-associated gastric adenocarcinoma: implication for the evaluation of intestinal metaplasia and tumors at the esophagogastric junction.
Shen B; Ormsby AH; Shen C; Dumot JA; Shao YW; Bevins CL; Gramlich TL
Cancer; 2002 Feb; 94(3):820-31. PubMed ID: 11857318
[TBL] [Abstract][Full Text] [Related]
6. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
McCluggage WG; Shah R; Connolly LE; McBride HA
Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
[TBL] [Abstract][Full Text] [Related]
7. The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas.
Tot T
Cancer; 2001 Nov; 92(10):2727-32. PubMed ID: 11745209
[TBL] [Abstract][Full Text] [Related]
8. Expression of CDX2, cytokeratins 7 and 20 in sinonasal intestinal-type adenocarcinoma.
Ortiz-Rey JA; Alvarez C; San Miguel P; Iglesias B; Antón I
Appl Immunohistochem Mol Morphol; 2005 Jun; 13(2):142-6. PubMed ID: 15894926
[TBL] [Abstract][Full Text] [Related]
9. [CK7, CK20, SOX10 and CDX2: expressions and diagnostic values in primary adenocarcinoma of the sinonasal tract].
Yue C; Piao Y; Bai Y; Liu H; Zhang L
Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(30):2447-50. PubMed ID: 26711206
[TBL] [Abstract][Full Text] [Related]
10. The Role of SATB2 as a Diagnostic Marker of Sinonasal Intestinal-type Adenocarcinoma.
Skalova A; Sar A; Laco J; Metelkova A; Miesbauerova M; Steiner P; Švajdler M; Michal M
Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):140-146. PubMed ID: 27258560
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical distinction of intestinal-type sinonasal adenocarcinoma from metastatic adenocarcinoma of intestinal origin.
Resto VA; Krane JF; Faquin WC; Lin DT
Ann Otol Rhinol Laryngol; 2006 Jan; 115(1):59-64. PubMed ID: 16466101
[TBL] [Abstract][Full Text] [Related]
12. Alteration of cytokeratin 7 and cytokeratin 20 expression profile is uniquely associated with tumorigenesis of primary adenocarcinoma of the small intestine.
Chen ZM; Wang HL
Am J Surg Pathol; 2004 Oct; 28(10):1352-9. PubMed ID: 15371952
[TBL] [Abstract][Full Text] [Related]
13. Expression of cytokeratins 7 and 20 in serrated adenoma and related diseases.
Tatsumi N; Mukaisho K; Mitsufuji S; Tatsumi Y; Sugihara H; Okanoue T; Hattori T
Dig Dis Sci; 2005 Sep; 50(9):1741-6. PubMed ID: 16133982
[TBL] [Abstract][Full Text] [Related]
14. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung].
Zou SM; Lin DM; Lü N; Liu XY; Wen P; Liu FS
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1350-2. PubMed ID: 12930693
[TBL] [Abstract][Full Text] [Related]
15. Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma.
Shah RN; Badve S; Papreddy K; Schindler S; Laskin WB; Yeldandi AV
Hum Pathol; 2002 Sep; 33(9):915-20. PubMed ID: 12378517
[TBL] [Abstract][Full Text] [Related]
16. Identifying colorectal metastases in liver biopsies: the novel CDX2 antibody is less specific than the cytokeratin 20+/7- phenotype.
Tot T
Med Sci Monit; 2004 May; 10(5):BR139-43. PubMed ID: 15114262
[TBL] [Abstract][Full Text] [Related]
17. [Value of cytokeratin 7 and 20 for the diagnosis of cerebral metastases of adenocarcinoma: study of 78 cases].
Fernandez C; Liprandi A; Bouvier-Labit C; Figarella-Branger D
Ann Pathol; 2001 Apr; 21(2):129-35. PubMed ID: 11373582
[TBL] [Abstract][Full Text] [Related]
18. Cytokeratin 7 immunoreactivity in rectal adenocarcinomas.
Zhang PJ; Shah M; Spiegel GW; Brooks JJ
Appl Immunohistochem Mol Morphol; 2003 Dec; 11(4):306-10. PubMed ID: 14663355
[TBL] [Abstract][Full Text] [Related]
19. The clinical relevance of cytokeratin phenotyping in needle biopsy of liver metastasis.
Tot T; Samii S
APMIS; 2003 Dec; 111(12):1075-82. PubMed ID: 14678015
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach.
Lagendijk JH; Mullink H; van Diest PJ; Meijer GA; Meijer CJ
J Clin Pathol; 1999 Apr; 52(4):283-90. PubMed ID: 10474521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]